Why Kraig Biocraft Laboratories Inc (OTCMKTS:KBLB) Boils with Potential on the Pullback

Why Kraig Biocraft Laboratories Inc (OTCMKTS:KBLB) Boils with Potential on the Pullback

SHARE

One of the hottest names on the OTC so far in 2019, Kraig Biocraft Laboratories Inc (OTCMKTS:KBLB), has been pulling back sharply in recent action and may have just shown signs of putting in key support. We would normally want to see a retest of the low of this pullback and successful signs of a clear chasing bid coming up under the action before declaring this a trading opportunity on the long-side for a possible retest of the highs. At this point, we would simply make sure to point it out and suggest it needs to be on the trading radar. To make matters more interesting, the company just announced that it has submitted five new provisional patent applications, for technologies related to its recombinant spider silk technologies.

According to the release, “These applications cover a broad range of technologies in the creation, screening, and production of new recombinant proteins. These new applications expand beyond the Company’s publicly disclosed silkworm and silk technologies, to include advanced construction systems, methods, and non-native proteins. In November, of 2018, the Company retained Workman Nydegger as its Intellectual Property counsel and expects to utilize their expertise in prosecuting these, and all future, patent applications.”

Kraig Biocraft Laboratories Inc (OTCMKTS:KBLB) bills itself as a company that focuses on developing protein based fibers using recombinant DNA technology for commercial applications in the textile and specialty fiber industries in the United States. This fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies.

KBLB has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Core product technology is aimed at military and police applications for ballistic protection; industrial applications, including critical cables and abrasion/impact resistant components; safety equipment; composite materials for the aero-space industry; and for ballistic protection by the defense industry.

Its products are also used in various markets, such as medical textiles, geo textiles, defense and military textiles, safe and protective clothing, filtration textiles, transportation textiles, textiles used in buildings, composites with textile structure, and functional and sportive textiles.

According to company materials, “Kraig Labs (OTC: KBLB) is the leading developer of genetically engineered spider silk based fiber technologies. Kraig’s recombinant spider silk fibers are lighter, stronger, and more flexible than traditional materials, offering unmatched material performance with sustainable and ecological manufacturing practices.”

Find out when $KBLB reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.

As noted above, KBLB just announced that it has submitted five new provisional patent applications, for technologies related to its recombinant spider silk technologies.

Traders will note just under 150% piled on for shareholders of the listing during the trailing month. Furthermore, the name has benefitted from a jump in recent trading volume to the tune of 470% above the average volume levels in play in this stock over the longer term.

“Our R&D team is constantly looking for opportunities to strengthen our competitive potions, products, and processes. The recently submitted provisional patent applications cover key technologies and processes, invented by Dr. Kane and our team, as well as new applications that build upon our technologies,” said Kraig’s COO Jon Rice. “These new technologies have the potential to significantly reduce future R&D costs and break open new markets for recombinant protein products, reaching far beyond silks and apparel.”

Currently trading at a market capitalization of $243.7M, KBLB has a stash ($908K) of cash on the books, which is balanced by about $4.4M in total current liabilities. KBLB is pulling in trailing 12-month revenues of $293K. However, the company is seeing declines on the top-line on a quarterly y/y basis. You can bet we will update this one again as new information comes into view. Sign-up for continuing coverage on shares of $KBLB stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: we hold no position in $KBLB, either long or short, and we have not been compensated for this article.

Sign Up for our 100% FREE Oracle Dispatch Newsletter